Cite
Understanding facilitators and barriers of direct‐acting antiviral therapy for hepatitis C virus infection in prison.
MLA
Lafferty, Lise, et al. “Understanding Facilitators and Barriers of Direct‐acting Antiviral Therapy for Hepatitis C Virus Infection in Prison.” Journal of Viral Hepatitis, vol. 25, no. 12, Dec. 2018, pp. 1526–32. EBSCOhost, https://doi.org/10.1111/jvh.12987.
APA
Lafferty, L., Rance, J., Grebely, J., Lloyd, A. R., Dore, G. J., & Treloar, C. (2018). Understanding facilitators and barriers of direct‐acting antiviral therapy for hepatitis C virus infection in prison. Journal of Viral Hepatitis, 25(12), 1526–1532. https://doi.org/10.1111/jvh.12987
Chicago
Lafferty, Lise, Jake Rance, Jason Grebely, Andrew R. Lloyd, Gregory J. Dore, and Carla Treloar. 2018. “Understanding Facilitators and Barriers of Direct‐acting Antiviral Therapy for Hepatitis C Virus Infection in Prison.” Journal of Viral Hepatitis 25 (12): 1526–32. doi:10.1111/jvh.12987.